Biotech: Page 47
-
PharmaVoice Team/PharmaVoice
Biotech: Raising Capital in a Tight Market
The global financial crisis has made it challenging for the biotechnology industry to raise capital to fund innovation. Experts say venture capital money is still available, but often the VC community is looking for lower-risk, short-term projects. As a result, biotech companies are increasingly ...
By Denise Myshko • Dec. 27, 2010 -
PharmaVoice Team/PharmaVoice
Achieving Global Launch Excellence
The details of what comprise a global launch vary depending upon who is doing the defining, but experts can agree that the launch environment is becoming more challenging. And with the value of the global pharmaceutical market expected to grow 5% to 7% in 2011, according to IMS Health, the incent...
By PharmaVoice Team • Dec. 27, 2010 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
The Genome: The Next 10 Years
In just one generation medicine will take a huge leap forward. That is, if researchers are right about how data from the human genome can be used to address disease. There has been a great deal of optimism about how sequencing the human genome might create new diagnostics and new medicines. Ten y...
By Denise Myshko • Dec. 27, 2010 -
PharmaVoice Team/PharmaVoice
Last Word
Pharma Forecast Simon King, a pharmaceutical company analyst at Datamonitor, comments on trends expected to impact “big pharma" in 2011. PV: Despite a challenging year for Roche, you say restructuring will help the company maintain a strong fiscal position. What other factors do you think will h...
By PharmaVoice Team • Dec. 27, 2010 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Dr. Milind DESHPANDE Achillion Pharmaceuticals Promotes R&D President Achillion Pharmaceuticals, which is focused on the discovery and development of small-molecule drugs to combat challenging infectious diseases, has promoted Chief Scientific Officer Milind Deshpande, Ph....
By PharmaVoice Team • Dec. 27, 2010 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: New Solutions Help Harness Social Monitoring Insights CRM Update In Other Technology News… AstraZeneca BioClinica Chiltern International Cmed Technology Decision Resources PharmaVigilant E-Upgrades and Enhancement...
By PharmaVoice Team • Dec. 27, 2010 -
PharmaVoice Team/PharmaVoice
What's New
Trends: Changing market forces and the trend toward more flexible business models have inspired the creation of dynamic companies better positioned to explore opportunities overlooked by larger life-sciences organizations. NEW AMERICAN THERAPEUTICS, a specialty pharmaceutical company co-founded ...
By PharmaVoice Team • Dec. 27, 2010 -
PharmaVoice Team/PharmaVoice
UpFront
Awards… Abbott Diversity Leader John F. Crowley Honored Rx club Awards Dr. Paul Janssen Award Industry at Large Merck & The Street Executive Moves — Changes at the Top Podcasts White papers » Abbott Diversity Leader Abbott has been named one of the top 10 companies for diversity in a new surv...
By PharmaVoice Team • Dec. 27, 2010 -
PharmaVoice Team/PharmaVoice
A Globally Focused Industry
There will be an overall shift in the pharmaceutical industry from a very Western-centric model to a global one. Disease areas that were once considered niche are now given priority and the more prevalent disease therapeutic areas in the mature markets have taken a backseat. Vaccines, biologics, ...
By Denise Myshko • Nov. 10, 2010 -
PharmaVoice Team/PharmaVoice
A More Conservative Regulatory Landscape
In the last few years, the FDA has come under strong criticism for the rate of adverse events, high-profile drug recalls, and contamination of both food and drug products. Agency officials have made steps to address drug safety and provide a more open and transparent regulatory environment. For t...
By PharmaVoice Team • Nov. 10, 2010 -
PharmaVoice Team/PharmaVoice
The Crystal Ball
Dr. John Arrowsmith Scientific Director Thomson Reuters, which delivers critical information to leading decision makers in the financial, legal, tax and accounting, healthcare, science, and media markets. For more information, visit lifesciencesconsulting.thomsonreuters.com. 1. Outsourcing. There...
By PharmaVoice Team • Nov. 10, 2010 -
PharmaVoice Team/PharmaVoice
Talent Pool
Biopharmaceutical POOL Michael BAILEY Dr. Donna RADZIK Aveo Pharmaceuticals Bolsters Leadership Aveo Pharmaceuticals, a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics, has appointed Michael Bailey chief commercial officer. Mr. Bailey joins Av...
By PharmaVoice Team • Nov. 9, 2010 -
PharmaVoice Team/PharmaVoice
Women in Science: A Work in Progress
It’s a fact that gender discrepancy in the field of science exists. It’s a fact that changes in legislation, academic policies, and an overall increased awareness of gender bias are improving a woman’s chances of succeeding in all the STEM (science, technology, engineering, and math) fields. Howe...
By PharmaVoice Team • Sept. 29, 2010 -
PharmaVoice Team/PharmaVoice
Tomorrow's MSL: Specialist or Generalist?
MSLs have been around for 40 years, and with the evolution of technology, increased regulations and government scrutiny, and the squeeze of the declining salesforce, today the role may be even more crucial to the drug-development and commercialization process. According to Robin Winter-Sperry, M....
By PharmaVoice Team • Sept. 29, 2010 -
PharmaVoice Team/PharmaVoice
Pharma is Taking Its Byte of the Apple
Sales reps have been using mobile CRM applications on their smart phones and laptops for years, but the larger screen and “wow" factor of the iPad may bring additional benefits and functions to bear. Novelty of iPad Increases Mobile Technology Demand With the recent emergence of more s...
By PharmaVoice Team • Sept. 29, 2010 -
PharmaVoice Team/PharmaVoice
Last Word
Current Challenges in BioScience What are some of the hot button issues in biotechnology today? Molineaux. For small companies, it is all about funding and the difficulties associated with raising capital. There is a great deal of risk aversion in the capital community today, which is making thin...
By PharmaVoice Team • Sept. 28, 2010 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: CenterWatch Service Matches Sponsors, Investigative Sites PPD, Microsoft Collaborate to Improve REMS Management Cegedim Dendrite Streamlines Tracking, Reporting Capabilities QPharma Assists with Marketing Spend ...
By PharmaVoice Team • Sept. 28, 2010 -
PharmaVoice Team/PharmaVoice
UpFront
Awards Sanofi-Aventis Receives HBA’s ACE Award The Healthcare Businesswomen’s Association (HBA) has named Sanofi-Aventis US as the winner of the 2010 HBA ACE Award. The Sanofi-Aventis US program, WISE (Women Inspiring Sanofi-Aventis Excellence), is an internal women’s network with more than 1,000...
By PharmaVoice Team • Sept. 28, 2010 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The appeal of the iPad… It’s hard not to be seduced by the power of the 9.7-inch, high-resolution LED-backlit IPS display and incredible multi-touch capabilities, all bundled in a sleek casing that is light enough to take anywhere. The iPad, what will Steve Jobs and his techno-creatives think of ...
By Taren Grom • Sept. 28, 2010 -
PharmaVoice Team/PharmaVoice
Last Word
USING MONOCLONAL ANTIBODIES What are the opportunities for using monoclonal antibodies to treat Alzheimer’s disease? CHAIN: It took a long time to understand the hallmarks of Alzheimer’s disease. The beta amyloid plaques that appear in the brains of patients with Alzheimer’s are just a sign of wh...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
The MENTORS
The MENTORS People’s People We salute those who take the time out of their own busy careers to help others to develop their paths to success; provide guidance; and exhibit patience, foresight, and unselfish devotion to mentoring. Knowledge is most valuable when shared, and Wendy Blackburn is one ...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
The TECHNOLOGISTS
Not many people have created two health-related companies, nor have had them both successfully acquired before their 30th birthday. But Hugo Stephenson, M.D., has an ability to see what others cannot and the energy to make things happens. As he says, he’s never yet met a challenge that could not ...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Dr. Mike BURGESS, Roche Dr. Mikael DOLSTEN, Pfizer Kenneth FRAZIER, Merck Adam SCHECHTER, Merck Biotechnology POOL Robert BRADWAY, Amgen Dr. Henry LI, Kylin Therapeutics Kenneth MOCH, Chimerix Dr. George PAINTER, Chimerix Dr. Thomas PITLER, Chimerix Biopharmaceutical POOL Dr. John ALA...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
2010 DIA Preview
PharmaVOICE is pleased to once again publish this Special Feature showcasing the new products, services, tools, and executive appointments and promotions at clinical-services companies that will be exhibiting at the DIA 46th Annual Meeting, June 13-17, 2010, in Washington, D.C. For your convenie...
By PharmaVoice Team • May 24, 2010 -
PharmaVoice Team/PharmaVoice
Last Word
GLOBAL NEEDS What do you think is the biggest global health need? Joseph. As citizens of the developed world, we don’t often think about infectious and tropical diseases but malaria and tuberculosis, along with HIV, are alarmingly prevalent among the poorest people in the world. Every year, these...
By PharmaVoice Team • May 24, 2010
Previous
